{ }
001122334455554433221100
001122334455554433221100

Pfizer appoints Chris Boshoff as new research and development chief

Pfizer has appointed Chris Boshoff as its new chief of research and development, effective January 1. Boshoff, who previously led the company"s cancer research and marketing, takes over from Mikael Dolsten, who stepped down after over 15 years. This leadership change comes amid pressure from activist investor Starboard and a decline in sales of Pfizer"s COVID-19 vaccine and antiviral Paxlovid, prompting a cost-cutting initiative.

Pfizer's RSV vaccine sales decline but market share shows promising growth

Pfizer's RSV vaccine, Abrysvo, generated $356 million in sales in Q3, down from $375 million last year, but the company reported a growing market share, exceeding 50% of shipped volume. Despite challenges from CDC guidelines affecting older adult uptake, maternal vaccination is seeing increased momentum. Pfizer is also advancing next-generation pneumococcal vaccines amid competition from Merck and Vaxcyte.

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.